Veterinary and Comparative Oncology

Papers
(The TQCC of Veterinary and Comparative Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma22
Issue Information16
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours15
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma14
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?14
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours14
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment13
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy13
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy13
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy13
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)12
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs12
Practice patterns about the role of palliation in veterinary surgical oncology12
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain11
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study11
Blood biomarkers for canine cancer, from human to veterinary oncology11
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping11
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study11
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma10
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review10
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria10
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin10
9
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu9
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas8
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells8
Issue Information8
Cover Image8
Corrigendum8
7
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs7
Author Index7
Issue Information7
Issue Information7
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus7
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma6
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs6
Issue Information6
6
6
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours6
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs6
Frontal sinus carcinoma in forty‐one dogs (2001–2022)6
Issue Information6
Issue Information6
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain6
Author Index5
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma5
Issue Information5
Outcome and postoperative complications in 73 dogs with thyroid carcinoma with gross vascular invasion managed with thyroidectomy5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment5
5
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk5
Comparison of the anticancer effects of various statins on canine oral melanoma cells5
5
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma5
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)5
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis4
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study4
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review4
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs4
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma4
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry4
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases4
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience4
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance4
4
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs4
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours3
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases3
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells3
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”3
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study3
Exploring optical coherence tomography imaging depth to differentiate tissues at surgical margins3
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases3
Issue Information3
Evaluating the relevance of surgical margins. Part one: The problems with current methodology3
Cyclical 10‐day dosing of melphalan for canine multiple myeloma3
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours3
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade3
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma3
3
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission3
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases3
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy3
VCS abstract3
The animal's microbiome and cancer: A translational perspective3
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study3
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol3
0.08358097076416